Not intended UK Media (IN BRIEF) Bayer and Cedilla Therapeutics have entered into an exclusive license agreement to develop and…
A new drug with the potential to reverse resistance to immunotherapy has been developed by scientists at the University of…
Pivotal PIONEER study compared safety and efficacy of the two compounds in the prevention of neutropenia in patients with breast…
Approval Establishes Genzyme’s MS Franchise in the U.S. with Two Approved Products; Follows Global Approvals PARIS, 17-11-2014 — /EuropaWire/ —…
Annual General Meeting of Shareholders 2014 Mannheim, Germany, 21-5-2014 — /EuropaWire/ — The Annual General Meeting of Shareholders of SAP AG today…
Trial expected to support registration in the U.S. and European Union Sandoz continues to advance biosimilar pipeline with seven Phase…
25-6-2013 — /europawire.eu/ — AstraZeneca today announced that MedImmune, its global biologics research and development arm, and NGM Biopharmaceuticals, Inc. have…